Optimized EPO Treatment of Neonatal Anemia
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 07 Dec 2017
At a glance
- Drugs Epoetin alfa (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Acronyms OETNA
- 01 Dec 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2018.
- 01 Dec 2017 Status changed from recruiting to active, no longer recruiting.
- 10 Jun 2017 Biomarkers information updated